| Graham D Dellinger, MD | |
|
1111 Ronald Reagan Pkwy, Avon, IN 46123-7085 | |
| (317) 217-2888 | |
| (317) 217-2999 |
| Full Name | Graham D Dellinger |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 9 Years |
| Location | 1111 Ronald Reagan Pkwy, Avon, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063808905 | NPI | - | NPPES |
| 201300880 | Medicaid | IN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Iu Health West Hospital | Avon, IN | Hospital |
| Indiana University Health | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana Clinic Critical Care Llc | 3678600988 | 206 |
News Archive
Just over 60 percent of individuals who died from an opioid overdose had been diagnosed with a chronic pain condition, and many had been diagnosed with a psychiatric disorder, a study of more than 13,000 overdose deaths has found.
Kindred Healthcare, Inc. today provided its estimate of the revenue effect of proposed rate changes to Medicare Part B therapy services included in the proposed Medicare Physician Fee Schedule rule. The proposed rule was released by the Centers for Medicare and Medicaid Services ("CMS") on June 25. The proposed rule is subject to a 60-day public comment period and is scheduled to become effective January 1, 2011.
Supportive care and quality-of-life issues should be considered essential elements of a multidisciplinary approach to breast cancer treatment at the point of breast cancer diagnosis. However, for women suffering from breast cancer in low- and middle-resource countries and other medically underserved areas around the world, this fundamental area of patient care generally is neglected and misunderstood.
Asan Medical Center and Chemizon, the drug discovery division of Optomagic, Co. Ltd., announced today that they have entered into a multi-year research collaboration to discover and develop novel, small molecule oncology therapeutics.
Nearly one-fifth of all metastatic breast cancer patients develop brain metastases and have significantly shorter overall survival than patients who do not have brain involvement. One way to improve the affected patients' survival might be to prevent the brain metastases from arising in the first place. With that in mind, researchers have been working on a predictive model that accurately identifies these high risk patients.
› Verified 6 days ago
| Entity Name | Indiana Clinic Critical Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417285230 PECOS PAC ID: 3678600988 Enrollment ID: O20100419000408 |
News Archive
Just over 60 percent of individuals who died from an opioid overdose had been diagnosed with a chronic pain condition, and many had been diagnosed with a psychiatric disorder, a study of more than 13,000 overdose deaths has found.
Kindred Healthcare, Inc. today provided its estimate of the revenue effect of proposed rate changes to Medicare Part B therapy services included in the proposed Medicare Physician Fee Schedule rule. The proposed rule was released by the Centers for Medicare and Medicaid Services ("CMS") on June 25. The proposed rule is subject to a 60-day public comment period and is scheduled to become effective January 1, 2011.
Supportive care and quality-of-life issues should be considered essential elements of a multidisciplinary approach to breast cancer treatment at the point of breast cancer diagnosis. However, for women suffering from breast cancer in low- and middle-resource countries and other medically underserved areas around the world, this fundamental area of patient care generally is neglected and misunderstood.
Asan Medical Center and Chemizon, the drug discovery division of Optomagic, Co. Ltd., announced today that they have entered into a multi-year research collaboration to discover and develop novel, small molecule oncology therapeutics.
Nearly one-fifth of all metastatic breast cancer patients develop brain metastases and have significantly shorter overall survival than patients who do not have brain involvement. One way to improve the affected patients' survival might be to prevent the brain metastases from arising in the first place. With that in mind, researchers have been working on a predictive model that accurately identifies these high risk patients.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Graham D Dellinger, MD 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Graham D Dellinger, MD 1111 Ronald Reagan Pkwy, Avon, IN 46123-7085 Ph: (317) 217-2888 |
News Archive
Just over 60 percent of individuals who died from an opioid overdose had been diagnosed with a chronic pain condition, and many had been diagnosed with a psychiatric disorder, a study of more than 13,000 overdose deaths has found.
Kindred Healthcare, Inc. today provided its estimate of the revenue effect of proposed rate changes to Medicare Part B therapy services included in the proposed Medicare Physician Fee Schedule rule. The proposed rule was released by the Centers for Medicare and Medicaid Services ("CMS") on June 25. The proposed rule is subject to a 60-day public comment period and is scheduled to become effective January 1, 2011.
Supportive care and quality-of-life issues should be considered essential elements of a multidisciplinary approach to breast cancer treatment at the point of breast cancer diagnosis. However, for women suffering from breast cancer in low- and middle-resource countries and other medically underserved areas around the world, this fundamental area of patient care generally is neglected and misunderstood.
Asan Medical Center and Chemizon, the drug discovery division of Optomagic, Co. Ltd., announced today that they have entered into a multi-year research collaboration to discover and develop novel, small molecule oncology therapeutics.
Nearly one-fifth of all metastatic breast cancer patients develop brain metastases and have significantly shorter overall survival than patients who do not have brain involvement. One way to improve the affected patients' survival might be to prevent the brain metastases from arising in the first place. With that in mind, researchers have been working on a predictive model that accurately identifies these high risk patients.
› Verified 6 days ago
Bhasker Reddy, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1115 N Ronald Reagan Parkway, Suite 206, Avon, IN 46123 Phone: 317-272-8050 Fax: 317-272-8051 | |
Namrata Shah, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 Ronald Reagan Pkwy Ste B1500, Avon, IN 46123 Phone: 317-217-2244 Fax: 317-217-2249 | |
Caitlin M Baxter, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123 Phone: 317-962-5820 Fax: 317-962-3916 | |
Dr. Stephen H Pollom, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1115 Ronald Reagan Pkwy, Ste 318, Avon, IN 46123 Phone: 317-217-2600 Fax: 317-217-2606 | |
Dr. David Lee Hyslop, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 6013 Yellow Birch Ct, Avon, IN 46123 Phone: 317-838-7096 | |
Michaela A Besold, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 8244 E Us Highway 36, Suite 1320, Avon, IN 46123 Phone: 317-272-7519 Fax: 317-272-3661 |